Pharmaceutical Qui Tam Cases On The Rise

As the cost of healthcare continues to rise, the government is taking a closer look at pharmaceutical companies that are engaging in Medicare fraud. Pharmaceutical Medicare fraud occurs when a pharmaceutical company or its representatives attempt to defraud the government by overcharging for drugs, upcoding, or submitting false claims. Pharmaceutical companies are particularly vulnerable to misuse of Medicare funds or false claims

Read More
 

Jacob Tubbs Cited By NPR About Fraudulent Hospital Admissions

Not all patients who are in the ER are admitted, and it is important that those that require in-patient levels of care are treated properly in the ER setting, but recent studies have shown that some for-profit hospital chains enact practices whereby they use quotas or incentives to fraudulently admit patients for inpatient care where

Read More
 

Medical Testing Fraud Draws Increasing Scrutiny from DOJ in Recent Whistleblower Cases

Over the previous months, the United States has intervened in multiple whistleblower cases involving unnecessary medical testing conducted by clinical laboratories and health care providers in several states. These cases demonstrate not only the increased scrutiny with which the DOJ has approached medical testing fraud under the False Claims Act (FCA) but also the vital

Read More
 

Looking Back: Important Qui Tam Cases From 2021

The Department of Justice (DOJ) recently released its 2021 False Claims Act (FCA) statistics. A near-record year, the DOJ reported over $5.6 billion recovered in FCA settlements and judgments.

The DOJ’s year-end review presents an excellent opportunity to look back to some of 2021’s most notable FCA cases brought by whistleblowers.

Read More
 

DOJ Announces $5.6 Billion Recovered in False Claims Act Cases Last Year–$1.6 Billion From Whistleblowers

The DOJ recently reported that it obtained more than $5.6 billion in FCA settlements and judgments last year, the second most ever in a year. Over $1.6 billion of this amount stemmed from lawsuits filed by whistleblowers. In total, whistleblowers filed 598 qui tam suits in 2021, and the government paid out over $237 million to whistleblowers.

Read More
 

Medical Testing and the False Claims Act

If the past year is any indication, companies and practitioners involved in medical testing are facing increasing scrutiny under the False Claims Act. We believe that recent trends show just how vital whistleblowers will be to addressing medical testing fraud in the near future.

Read More
 

Private Equity Firms Seeing Increasing Scrutiny Under the False Claims Act–Emerging Trends

Private equity firms are facing increasing scrutiny under the False Claims Act (FCA). Recently, the Massachusetts Attorney General announced the largest reported healthcare fraud settlement against a private equity firm, amounting to $25 million. The case was brought under the qui tam provisions of Massachusetts’s FCA. Earlier this year, the DOJ reported a $15.3 million

Read More
 

Recent Trends in False Claims Act Litigation

Recent trends in False Claims Act litigation show high rates of settlement, increases in damage awards, and a high prevalence of health care defendants. At Price Armstrong, we think these trends indicate a future push to hold health care fraudsters accountable through whistleblower False Claims actions.

Read More
 

Whistleblower Gets $24 Million in First Ever Award From National Highway Traffic Safety Administration

The National Highway Traffic Safety Administration recently awarded its first-ever whistleblower award to a former Hyundai safety engineer who brought allegations of faulty engine designs against Hyundai and Kia. Kim Gwang-ho, the whistleblower, received $24.3 million for reporting the defective engines.

Read More
 

The False Claims Amendment Act Turns 35–A Look at its Past, Present, and Future

The False Claims Amendment Act of 1986 recently celebrated its 35th anniversary. This monumental law helped revitalized the Civil War-era False Claims Act to help better prevent fraud through the use of private whistleblowers.

Read More